Cationic Antimicrobial Peptides for Multidrug-Resistant Bacteria
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimicrobial peptides face challenges in achieving systemic efficacy and safety due to toxicity and limited structural optimization, particularly against multidrug-resistant bacteria, with existing AMPs often failing in advanced clinical phases and lacking definitive structure-function correlations.
Innovation Solution
Development of cationic amphipathic polypeptides (PAX) with specific sequences and compositions, including tryptophan and arginine residues, designed to enhance antibacterial potency while minimizing host toxicity, using a rational framework that controls Trp content, positioning, length, and charge to achieve selective antibacterial activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional amino acid-based AMPs are used, then antimicrobial activity is achieved, but host toxicity increases and clinical efficacy fails
Solution Approach 1:
The patent changes the chemical parameters of AMPs by incorporating non-conventional amino acids (N-cas amino acids) with modified side chain properties. This includes using amino acids with reduced hydrophobicity or altered charge distributions, which fundamentally changes the interaction profile with host cells versus bacterial membranes, thereby reducing toxicity while preserving antimicrobial activity
Solution Approach 2:
The patent creates composite peptide structures by combining conventional amino acids with N-cas amino acids in specific ratios and positions. This composite approach allows the peptide to exhibit both the membrane-disrupting properties needed for antimicrobial activity and the reduced host cell affinity needed for lower toxicity, achieving a balanced therapeutic profile
2Reliability
If AMP potency is increased to combat MDR bacteria, then antibacterial activity improves, but selectivity against host cells decreases
Solution Approach 1:
The patent applies local quality by positioning specific N-cas amino acids with particular side chain properties at strategic locations within the peptide sequence. For example, amino acids with moderate hydrophobicity are placed at the hydrophobic face of the amphipathic helix to enhance bacterial membrane interaction, while amino acids with reduced cationic charge are positioned at the interface region to minimize non-specific binding to host cell membranes
Solution Approach 2:
The patent modifies the charge parameter and hydrophobicity parameter of specific residues within the peptide. By using N-cas amino acids with tuned pKa values and side chain volumes, the peptide achieves stronger interaction with the negatively charged bacterial outer membrane while maintaining weaker interaction with the more complex, cholesterol-rich host cell membranes, thereby improving selectivity
3Reliability
If structural optimization is performed to enhance AMP activity, then antibacterial efficacy improves, but development time and complexity increase
Solution Approach 1:
The patent systematically varies key structural parameters including peptide length (12-20 residues), net charge (+2 to +6), hydrophobicity index, and amino acid composition ratios. By establishing structure-activity relationships through controlled parameter variation, the patent identifies optimal ranges that deliver high efficacy without requiring excessive structural complexity, thereby streamlining the design process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The PAX peptides demonstrate broad efficacy against multidrug-resistant bacteria, including strains resistant to traditional antibiotics, with reduced toxicity to mammalian cells, effectively uncoupling antibacterial activity and host toxicity, and showing therapeutic potential in animal models of infection.
Implementation Method 1
The membrane-perturbing mechanism of many antimicrobial peptides
Implementation Method 2
amphipathic polypeptides (PAX) with specific sequences and compositions, including tryptophan and arginine residues, designed to enhance antibacterial potency while minimizing host toxicity
Data Source
AI summary
Provided herein are compositions comprising an antimicrobial cationic amphipathic polypeptide (PAX) and methods of using the same for treatment of a microbial infection